AMP-Coated TiO2 Doped ZnO Nanomaterials Enhanced Antimicrobial Activity and Efficacy in Otitis Media Treatment by Elevating Hydroxyl Radical Levels
DOI: https://doi.org/10.2147/ijn.s449888
IF: 7.033
2024-03-27
International Journal of Nanomedicine
Abstract:Qianyu Bai, 1, &ast Yichi Zhang, 1, &ast Runqiu Cai, 1 Haiyan Wu, 1 Huiqun Fu, 2 Xuemei Zhou, 2 Jie Chai, 3 Xuepeng Teng, 3 Tianlong Liu 1 1 National Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agriculture University, Beijing, People's Republic of China; 2 101 Institute of the Ministry of Civil Affairs, Beijing, People's Republic of China; 3 Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xuemei Zhou, 101 Institute of the Ministry of Civil Affairs, South Fourth Ring West Road No.188, Beijing, 100070, Email ; Tianlong Liu, College of Veterinary Medicine, China Agriculture University, Yuanmingyuan West Road No. 2, Beijing, 100193, Email Background: In the past decades, antimicrobial resistance (AMR) has been a major threat to global public health. Long-term, chronic otitis media is becoming more challenging to treat, thus the novel antibiotic alternative agents are much needed. Methods: ZnO@TiO 2 @AMP (ATZ NPs) were synthesized through a solvothermal method and subjected to comprehensive characterization. The in vitro and in vivo antibacterial effect and biocompatibility of ATZ NPs were evaluated. For the antibacterial mechanism exploration, we utilized the Electron Paramagnetic Resonance (EPR) Spectrometer to detect and analyze the hydroxyl radicals produced by ATZ NPs. Results: ATZ NPs exhibited a spherical structure of 99.85 nm, the drug-loading rate for ZnO was 20.73%, and AMP within ATZ NPs was 41.86%. Notably, the Minimum Inhibitory Concentration (MIC) value of ATZ NPs against Staphylococcus aureus ( S. aureus ), methicillin-resistant Staphylococcus aureus (MRSA), and Streptococcus pneumoniae ( S. pneumoniae ) were 10 μg/mL, and Minimum Bactericidal Concentration (MBC) value of ATZ NPs against S. aureus , and S. pneumoniae were 50 μg/mL. In comparison to the model group, the treatment of otitis media with ATZ NPs significantly reduces inflammatory exudation in the middle ear cavity, with no observable damage to the tympanic membrane. Both in vivo and in vitro toxicity tests indicating the good biocompatibility of ATZ NPs. Moreover, EPR spectroscopy results highlighted the superior ability of ATZ NPs to generate hydroxyl radicals (·OH) compared to ZnO NPs. Conclusion: ATZ NPs exhibited remarkable antibacterial properties both in vivo and in vitro. This innovative application of advanced ATZ NPs, bringing great promise for the treatment of otitis media. Keywords: nanoparticles, otitis media, zinc oxide, mesoporous titanium dioxide, antimicrobial peptide, antimicrobial, hydroxyl radical In the past decades, antimicrobial resistance (AMR) has been a major threat to global public health. 1,2 With the increasing emergence of multi-drug resistant (MDR) bacteria, we have entered the post-antibiotic era, there is an urgent demand for the discovery and development of novel, highly effective antibiotic candidates. 3–5 Inflammation in the ear, particularly otitis media, poses considerable treatment challenges due to the ear canal's unique anatomy, hindering direct access for therapeutic drugs. As AMR problem worsens, there is a lack of ideal medications for otitis media treatment, and severe cases may result in hearing impairment. 6–9 To tackle this, researchers have been striving to develop novel antibiotic alternatives, such as zinc oxide nanoparticles (ZnO NPs), titanium dioxide nanoparticles (TiO 2 NPs), and antimicrobial peptides (AMPs). Each of these drugs has its own strengths in antibacterial properties, yet they also come with their own limitations. ZnO NPs, typically around 10 nm in size, exhibit notable antimicrobial properties by generating reactive oxygen species (ROS) on bacterial membranes, presenting a promising agent for combating such infections. 10–12 However, these tiny ZnO NPs exhibit poor selectivity to cells and significant cytotoxicity. 13,14 Mesoporous core-shell TiO 2 NPs have specific surface area, narrow pore size distribution, photochemical stability, and the capacity for surface properties modification. 15–18 TiO 2 NPs can also produce ROS under ultraviolet (UV) photocatalysis. However, its antibacterial properties are limited due to the dependence of UV light. Studies have shown that by doping with ZnO NPs, the light absorption range of TiO 2 nanoparticles can b -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology